Table 3. Patients with suggested changes to stage and/or treatment strategy due to 18F-FDG-PET.
Stage |
|||||
---|---|---|---|---|---|
Patient no. | Disease status (P, R) | Standard | PET | Change in stage | Change in treatment |
1 | P | IIIA | IIA | Downstaging | Minimisation |
2 | R | IAE | IVA | Upstaging | Intensification |
3 | P | IIIB | IIB | Downstaging | No change |
4 | P | IIIA | IVA | Upstaging | No change |
5 | R | IIAE | IIIAE | Upstaging | Intensification |
6 | R | IIB | IIIB | Upstaging | Intensification |
7 | P | IVA | IIA | Downstaging | Minimisation |
8 | P | IIIA | IA | Downstaging | Minimisation |
9 | P | IIA | IIIA | Upstaging | Intensification |
10 | P | IIIAE | IIAE | Downstaging | Minimisation |
11 | P | IIA | IIAE | No change | Intensification |
12 | P | IIB | IB | Downstaging | Minimisation |
13 | P | IIA | IIIAE | Upstaging | Intensification |
14 | P | IIA | IVA | Upstaging | Intensification |
15 | P | IA | IIA | Upstaging | No change |
16 | P | IIIB | IVB | Upstaging | No change |
17 | P | IIA | IIA | No change | Intensification |
18 | P | IIA | IIA | No change | Minimisation |
19 | P | IIA | IA | Downstaging | Minimisation |
20 | P | IIIB | IVB | Upstaging | No change |
21 | P | IIIB | IVB | Upstaging | No change |
22 | P | IIA | IIAE | No change | Intensification |
P=primary diagnosis, R=recurrent disease.